Statements (35)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1996
|
| gptkbp:ATCCode |
J01DE01
|
| gptkbp:CASNumber |
88040-23-7
|
| gptkbp:chemicalFormula |
C19H24N6O5S2
|
| gptkbp:contraindication |
hypersensitivity to cephalosporins
|
| gptkbp:drugClass |
cephalosporin
|
| gptkbp:eliminationHalfLife |
2 hours
|
| gptkbp:excretion |
urine
|
| gptkbp:genericName |
gptkb:cefepime
|
| https://www.w3.org/2000/01/rdf-schema#label |
Maxipime
|
| gptkbp:indication |
gptkb:pneumonia
gptkb:Bacteria urinary tract infection febrile neutropenia skin infection intra-abdominal infection |
| gptkbp:KEGGID |
D00255
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:MedlinePlusID |
a601206
|
| gptkbp:metabolism |
renal
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:proteinBinding |
16-19%
|
| gptkbp:PubChem_CID |
5479530
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
gptkb:seizure
nausea diarrhea allergic reaction rash |
| gptkbp:UNII |
U245E6I8E4
|
| gptkbp:bfsParent |
gptkb:cefepime
|
| gptkbp:bfsLayer |
7
|